Details of the Drug Reposition

General Information of This Drug (ID: DM5PRLA)

• Drug Name: Fasinumab (DM5PRLA)

Information on Drug Reposition of This Drug

4 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Neuropathic pain	DISC905E	8E43.0	Phase 3	[1]
Osteoarthritis	DIS05URM	FA00-FA05	Phase 3	[1]
Chronic low back pain	DISFIFVC	MG30.02	Phase 3	[1]
Pain	DIS4RWOW	MG30-MG3Z	Phase 3	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)